1. How do I register?

To register for ICDDTM’20, please fill in the Conference Registration Form. Once you have paid the registration fee, you have successfully registered for ICDDTM’20.

All participants must register for the conference, including those who are not going to present a poster or give a talk.

2. Which category should I register for?

The ICDDTM’20 registration categories are divided into:

  • Two-Day Conference
  • One-Day Workshop
  • Two-Day Conference & One-Day Workshop
  • One-Day Conference

Participants who register before 31st August 2020 are eligible for the early-bird rates.

If you are a MACR member, you will get a RM 50 discount for the registration fee. Please make sure you choose your registration category carefully.

Please note that for student registration, a valid student ID is required. Students are required to enclose a scanned copy of their student ID during registration for verification purposes.

3. How can I pay my registration fee?

Payment can be made via cheque deposit, electronic fund transfer or cash to:

  • Account name: Persatuan Penyelidikan Kanser Malaysia
  • Account number: 5121 4752 4724
  • Bank name: Malayan Banking Berhad (MAYBANK)
  • Swift Code: MBBEMYKL
  • Description: Registration fee for 1st MSC

If you are making payment via local order (LO) or research grant, please contact us for further payment arrangement. You may send your request to icddtm20.finance@macr-cancer.org

4. How do I know my registration is successful?

Once we have verified your payment, we will send a confirmation email to your registered email account.

5. What are the key registration deadlines?

31st August 2020 – Early Bird Registration Deadline
31st October 2020 – Normal Rate Registration Deadline
2nd3rd December 2020 – Conference Dates

6. How can I cancel my registration?

To cancel your congress registration, please contact icddtm20@macr-cancer.org

Please note: For written cancellations received before 15th October 2020, the cancellation fee is RM100. Thereafter, no refund will be possible.

7. How do I apply for the visa? How do I obtain an invitation letter?

Delegates who require a visa to enter Malaysia will be issued an invitation letter by the secretariat upon request. Please send your request to icddtm20@macr-cancer.org. Please note that an invitation letter will only be issued to those participants who have paid the registration fee in full.

8. How do I get the receipt for my payment?

We will send an electronic receipt to your registered email address, once we have verified your payment.


1. How do I submit an abstract?

Please follow our abstract guidelines and template for the preparation of your abstract. When the abstract is ready, please send it to the scientific committee at icddtm20.scientific@macr-cancer.org.

2. When is the deadline for abstract submission?

31st July 2020

3. When will I find out whether my abstract has been accepted?

All authors will be notified of the status of their abstracts latest by 31st August 2020.

4. How many abstracts can I submit?

An author may submit only one abstract as first author. However, we do not limit the number of abstracts one can appear in as co-author.

5. Will my abstract be published?

All accepted abstracts will be published in Frontiers in Pharmacology (IF 3.845) as an e-book, provided that the first author has registered for the conference and paid the registration fee.

6. If I am asked to publish a full article in Frontiers in Pharmacology, will I have to pay an article processing charge (APC)?

Yes. However, you may apply for an APC waiver or discount. You can find more information about the APC and the waiver application here: https://www.frontiersin.org/about/publishing-fees.


1. What are the presentation formats and is there a time limit for the presentations?

a) Oral presentation

Please find the guideline for the oral presentation here.

b) Poster presentation

Please find the guideline for the poster presentation here.

2. Why am I not in my preferred presentation category?

The author may state their preference for the type of presentation (oral or poster). The final decision of oral presentation, however, lies with the Scientific Committees given the limited slots available for parallel sessions.